Home › Funds › Caption Management, LLC › ABT

Caption Management, LLC position in ABT

ABBOTT LABORATORIES · Health Care

Caption Management, LLC reported holding 300,000 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$29.6M, representing 0.42% of its reported portfolio and ranking #41 among its reported holdings. Caption Management, LLC has disclosed ABT holdings in 8 of the last 12 reported quarters, going back to Q4 2023.

Latest position (Q3 2026)300.00K sh
Reported value held$29.65M
Portfolio Weight0.42%
First reportedQ4 2023
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Caption Management, LLC's ABT position evolved

Caption Management, LLC first disclosed a stake in ABT in Q4 2023 at 24,700 shares (US$2.7M). The position peaked in Q3 2026 at 300,000 shares, worth US$29.6M. Across 8 filings, Caption Management, LLC increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 300,000 shares valued at US$29.6M — an increase of 288,000 shares quarter over quarter.. Notable position changes include a 87% trim in Q3 2025 (shares fell 6% over the following quarter), a 3233% increase in Q4 2025 (shares fell 18% over the following quarter), a 2400% increase in Q3 2026 (shares rose 10% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 24.70K $2.72M New
Q2 2024 41.00K $4.26M New
Q1 2025 14.10K $1.87M New
Q2 2025 22.70K $3.09M Add
Q3 2025 3.00K $401.82K Reduce
Q4 2025 100.00K $12.53M Add
Q2 2026 12.00K $1.09M New
Q3 2026 300.00K $29.65M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 20 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.65B), Charles Schwab Investment Management (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has Caption Management, LLC held ABT?

Caption Management, LLC has disclosed ABT holdings in 8 of the last 12 reported quarters, going back to Q4 2023.

What is Caption Management, LLC's current position in ABT?

As of Q3 2026, Caption Management, LLC holds 300.00K shares of ABT (ABBOTT LABORATORIES), valued at $29.65M, representing 0.42% of its reported portfolio and ranking #41.

Has Caption Management, LLC been buying or selling ABT?

In the latest 13F filing (Q3 2026), Caption Management, LLC increased its position in ABT. The position peaked in Q3 2026 at 300.00K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, Charles Schwab Investment Management, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.